General Announcement::iX Biopharma Announces Positive Results from Pivotal Study of Erectile Dysfunction Drug

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
13-Sep-2016 17:16:43
Status
New
Announcement Sub Title
iX Biopharma Announces Positive Results from Pivotal Study of Erectile Dysfunction Drug
Announcement Reference
SG160913OTHRHFTM
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

News Release - iX Biopharma Announces Positive Results from Pivotal Study of Erectile Dysfunction Drug.pdf
Total size =64K